Literature DB >> 20413990

Association between baseline kidney function and change in CRP: an analysis of the cardiovascular health study.

Dena E Rifkin1, Ronit Katz, Linda F Fried, Bryan Kestenbaum, Nancy Swords Jenny, Anne B Newman, David S Siscovick, Michael G Shlipak, Mark J Sarnak.   

Abstract

BACKGROUND: In cross-sectional analyses, C-reactive protein (CRP) levels are inversely related to levels of kidney function. The relationship between kidney function and subsequent changes in CRP is unknown.
METHODS: We studied 4,364 individuals from the Cardiovascular Health Study, a longitudinal cohort of community-dwelling older adults. Baseline eGFRcys was estimated using cystatin C. CRP was measured at baseline and after 3 and 7 years of follow-up; slopes of change in CRP were calculated.
RESULTS: The mean (SD) age of the cohort was 72 (5.2) years; mean (SD) eGFRcys was 78.9 (18.4) ml/min/1.73 m(2). The median (interquartile range IQR) baseline CRP was 2.39 (1.22, 4.33) mg/l; the median (IQR) yearly change in CRP was -0.0051 (-0.020 to 0.27) mg/l/year. After adjustment for demographic characteristics and the initial level of CRP, each standard deviation lower baseline eGFR was associated with a small and non-significant yearly increase in CRP (0.032 mg/l/year; 95% CI: -0.005 to 0.070, p = 0.094).
CONCLUSIONS: We did not find a relationship between eGFR and subsequent changes in CRP. The association between kidney function and CRP in cross-sectional analyses may reflect unmeasured confounding by atherosclerosis; alternatively, the burden of comorbidity and interval mortality in this population may have masked a stronger longitudinal association between kidney function and change in CRP. Further study in younger populations may clarify whether impaired kidney function leads to change in inflammation over time. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20413990      PMCID: PMC2892648          DOI: 10.1159/000312874

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  24 in total

Review 1.  New approaches to the treatment of calcium and phosphorus abnormalities in patients on hemodialysis.

Authors:  K Uhlig; M J Sarnak; A K Singh
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-11       Impact factor: 2.894

Review 2.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

3.  C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease.

Authors:  Vandana Menon; Tom Greene; Xuelei Wang; Arema A Pereira; Santica M Marcovina; Gerald J Beck; John W Kusek; Alan J Collins; Andrew S Levey; Mark J Sarnak
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

4.  Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.

Authors:  Marc S Sabatine; David A Morrow; Kathleen A Jablonski; Madeline Murguia Rice; J Wayne Warnica; Michael J Domanski; Judith Hsia; Bernard J Gersh; Nader Rifai; Paul M Ridker; Marc A Pfeffer; Eugene Braunwald
Journal:  Circulation       Date:  2007-03-19       Impact factor: 29.690

5.  Effect of hyperinsulinemia on renal function in a general Japanese population: the Hisayama study.

Authors:  M Kubo; Y Kiyohara; I Kato; H Iwamoto; K Nakayama; H Hirakata; M Fujishima
Journal:  Kidney Int       Date:  1999-06       Impact factor: 10.612

6.  Inflammation and cardiovascular risk in dialysis patients.

Authors:  Christoph Wanner; Josef Zimmermann; Susanne Schwedler; Thomas Metzger
Journal:  Kidney Int Suppl       Date:  2002-05       Impact factor: 10.545

7.  Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study.

Authors:  Mark J Sarnak; Anthony Poindexter; Shin-Ru Wang; Gerald J Beck; John W Kusek; Santica M Marcovina; Tom Greene; Andrew S Levey
Journal:  Kidney Int       Date:  2002-12       Impact factor: 10.612

8.  Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.

Authors:  Michael G Shlipak; Linda F Fried; Mary Cushman; Teri A Manolio; Do Peterson; Catherine Stehman-Breen; Anthony Bleyer; Anne Newman; David Siscovick; Bruce Psaty
Journal:  JAMA       Date:  2005-04-13       Impact factor: 56.272

9.  C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.

Authors:  J Y Yeun; R A Levine; V Mantadilok; G A Kaysen
Journal:  Am J Kidney Dis       Date:  2000-03       Impact factor: 8.860

10.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.